Market Tracker

04/21 5:34am ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

205.21
Delayed Data
As of Apr 20
 -0.11 / -0.05%
Today’s Change
106.00
Today|||52-Week Range
211.57
+43.39%
Year-to-Date

Today’s Trading

Previous close205.32
Today’s open206.54
Day’s range203.23 - 206.72
Volume976,561
Average volume (3 months)2,875,996
Market cap$70.0B
Dividend yield--
Data as of 04/20/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+26.42%
Earnings growth (next 5 years)+26.30%
Revenue growth (last year)+43.22%
P/E ratio76.7
Price/Sales5.83
Price/Book12.92

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.38+0.82%
LLYEli Lilly and Co-0.06-0.08%
AZNAstraZeneca+0.23+0.32%
CELGCelgene+1.28+1.13%
Data as of 04/20/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)$2.33
Annual revenue (last year)$8.3B
Annual profit (last year)$913.5M
Net profit margin11.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer, Director &
Executive VP
Howard Bradley Schiller
Corporate headquarters
Laval, Quebec

Forecasts